Dolutegravir/lamivudine FDC recommended by NHS England

12 March 2020. Related: Treatment access.

Simon Collins, HIV i-Base

On 12 March 2020 the specialised commissioning document for dolutegravir/lamivudine was published.

The was after what is alwasy a long protracted process, even with the best intentions for faster access.

Doctors should now be able to prescriber this single-pill formulation, in line with prescribing guidelines.

Reference

NHS England. Dolutegravir / lamivudine for the treatment of Human Immunodeficiency Virus (HIV-1) infected adults and adolescents over 12 years of age
https://www.england.nhs.uk/publication/dolutegravir-lamivudine-for-the-treatment-of-human-immunodeficiency-virus-hiv-1-infected-adults-and-adolescents-over-12-years-of-age